Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Research Promises Five-Fold Reduction of Footrot in Sheep
University of Warwick has revealed research set to reduce footrot in sheep.

Researchers at the University of Warwick have shown that proper management of footrot has the potential to cut lameness from one in ten to one in fifty sheep.

The research promises a transformation in tackling the endemic disease, which causes lameness in around 9 million ewes and lambs in Great Britain every year.

The research has prompted the Sheep Veterinary Society to draft new recommendations, to be published nationally, on the treatment and control of footrot and interdigital dermatitis in sheep.

The treatment has been tested in India and is as effective there as it is in the UK.

Professor Laura Green, who led the research team, said: “Footrot is contagious and extremely painful for diseased sheep, and costly to the farming industry.

“Our research is significant because it can have an immediate impact on the disease with rapid cure  in three to five days, minimising the time that sheep are lame as well as increasing productivity for farmers.”

The work is part of a £1.4 million Biotechnological and Biological Sciences Research Council (BBSRC)-funded project at the University of Warwick, in collaboration with the University of Bristol.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.